The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
ChartZero

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Fri., Jul. 1, 8:09 PM

Slide #1. TESARO, Inc. Secondary Offering

Company: TESARO, Inc. (NASDAQ:TSRO)
Date announced: 6/30/2016
Shares Offered: 4,650,000
Date of Pricing: 6/30/2016
Price Per Share: $81.00
Secondary Offering Details: TESARO, Inc. (NASDAQ:TSRO) announced today that it has commenced an underwritten public offering of $300 million of its common stock. In connection with this offering, TESARO plans to grant the underwriters an option to purchase up to an additional $45 million of its common stock. Citigroup, Leerink Partners, Credit Suisse and Wells Fargo Securities are acting as bookrunners, and Mizuho, Raymond James, SunTrust Robinson Humphrey and Wedbush PacGrow are acting as co-managers for the offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.-updated 6/30- TESARO, Inc. (Nasdaq:TSRO) announced today that it has priced an underwritten public offering of an aggregate of 4,650,000 shares of its common stock at an offering price to the public of $81.00 per share. The gross proceeds from the offering will be approximately $376.7 million. In addition, TESARO has granted the underwriters an option to purchase up to an additional $56.5 million of its common stock. TESARO estimates that the net proceeds from the offering will be approximately $355.6 million after deducting the underwriting discount and other offering expenses payable by TESARO, but excluding any exercise of the underwriters' option.

TESARO is an oncology-focused biopharmaceutical company. Co. has in-licensed and is developing three clinical-stage product candidates: rolapitant, which is a neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting; niraparib, in which Co. is collaborating with the Sarcoma Alliance for Research through Collaboration to evaluate niraparib in combination with temozolomide for the treatment of Ewing's sarcoma; and TSR-011, which is an orally available targeted anti-cancer agent that is an inhibitor of both anaplastic lymphoma kinase and tropomyosin-related kinase in a Phase 1/2a dose escalation clinical trial in cancer patients.

TSRO SEC Filing Email Alerts Service

Open the TSRO Page at The Online Investor »

Company Name:  Tesaro Inc
Website:  www.tesarobio.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding TSRO:  19
Total Market Value Held by ETFs:  $173.41M
Total Market Capitalization:  $3.55B
% of Market Cap. Held by ETFs:  4.89%
 

Open the TSRO Page at The Online Investor (in a new window) »

List of Secondary Stock Offerings in this Slideshow:

6/15/2016:
Company: BioTime, Inc. (BTX)
Shares Offered: 7,322,176
More: offering details »

6/15/2016:
Company: Canadian Zinc Corporation (CZN.CA)
More: offering details »

6/15/2016:
Company: Earthstone Energy, Inc. (ESTE)
Shares Offered: 4,500,000
More: offering details »

6/15/2016:
Company: TETRA Technologies, Inc. (TTI)
Shares Offered: 10,000,000
More: offering details »

6/15/2016:
Company: Dynegy Inc. (DYN)
Shares Offered: 4,000,000
More: offering details »

6/16/2016:
Company: GlycoMimetics, Inc. (GLYC)
Shares Offered: 3,300,000
More: offering details »

6/16/2016:
Company: SemGroup Corporation (SEMG)
Shares Offered: 7,500,000
More: offering details »

6/20/2016:
Company: Global Blood Therapeutics, Inc. (GBT)
Shares Offered: 6,400,000
More: offering details »

6/20/2016:
Company: Medgenics, Inc. (MDGN)
Shares Offered: 3,640,000
More: offering details »

6/20/2016:
Company: Paratek Pharmaceuticals, Inc. (PRTK)
Shares Offered: 4,250,000
More: offering details »

6/20/2016:
Company: SCYNEXIS, Inc. (SCYX)
Shares Offered: 9,375,000
More: offering details »

6/21/2016:
Company: Planet Fitness, Inc. (PLNT)
Shares Offered: 10,000,000
More: offering details »

6/21/2016:
Company: Communications Sales & Leasing, Inc. (CSAL)
Shares Offered: 14,681,071
More: offering details »

6/21/2016:
Company: American Homes 4 Rent (AMH)
More: offering details »

6/21/2016:
Company: QEP Resources, Inc. (QEP)
Shares Offered: 20,000,000
More: offering details »

6/21/2016:
Company: Cott Corporation (COT)
Shares Offered: 13,120,000
More: offering details »

6/22/2016:
Company: Cascadian Therapeutics, Inc. (CASC)
Shares Offered: 35,000,000
More: offering details »

6/23/2016:
Company: Cascadian Therapeutics, Inc. (CASC)
Shares Offered: 17,250
More: offering details »

6/28/2016:
Company: National Storage Affiliates Trust (NSA)
Shares Offered: 10,475,000
More: offering details »

6/28/2016:
Company: Healthcare Realty Trust Incorporated (HR)
Shares Offered: 8,000,000
More: offering details »

6/28/2016:
Company: Eclipse Resources Corporation (ECR)
Shares Offered: 37,500,000
More: offering details »

6/28/2016:
Company: Blue Buffalo Pet Products, Inc. (BUFF)
Shares Offered: 15,000,000
More: offering details »

6/29/2016:
Company: Southwestern Energy Company (SWN)
Shares Offered: 86,000,000
More: offering details »

6/29/2016:
Company: Brixmor Property Group Inc. (BRX)
Shares Offered: 20,000,000
More: offering details »

6/30/2016:
Company: TESARO, Inc. (TSRO)
Shares Offered: 4,650,000
More: offering details »

July 1, 2016    8:09 PM Eastern
Quotes delayed 20 minutes



Strong Buy (3.75 out of 4)
79th percentile
(ranked higher than approx. 79% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | www.TheOnlineInvestor.com | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.